PolyProx Therapeutics Overview

  • Year Founded
  • 2018

Year Founded

  • Status
  • Out of Business

  • Employees
  • 9

Employees

  • Latest Deal Type
  • Liquidation

PolyProx Therapeutics General Information

Description

Manufacturer and developer of novel drugs designed to provide new therapies for cancer treatment. The company's drugs use a protein that selectively targets tumor cells and triggers natural degradation machinery within the cell, enabling cancer patients to benefit from the treatment that targets and removes disease-causing proteins.

Contact Information

Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Corporate Office
  • Jonas Webb Building B910
  • Babraham Research Campus
  • Cambridge CB22 3AT
  • England, United Kingdom
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • Jonas Webb Building B910
  • Babraham Research Campus
  • Cambridge CB22 3AT
  • England, United Kingdom

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

PolyProx Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Bankruptcy: Liquidation 25-Jan-2022 Completed Bankruptcy: Liquidation
3. Seed Round 02-Mar-2020 Completed Generating Revenue
2. Seed Round 01-Mar-2019 $4.44M $4.44M Completed Generating Revenue
1. University Spin-Out 07-Nov-2018 Completed Startup
To view PolyProx Therapeutics’s complete valuation and funding history, request access »

PolyProx Therapeutics Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Ordinary
Ordinary
To view PolyProx Therapeutics’s complete cap table history, request access »

PolyProx Therapeutics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

PolyProx Therapeutics FAQs

  • When was PolyProx Therapeutics founded?

    PolyProx Therapeutics was founded in 2018.

  • Where is PolyProx Therapeutics headquartered?

    PolyProx Therapeutics is headquartered in Cambridge, United Kingdom.

  • What is the size of PolyProx Therapeutics?

    PolyProx Therapeutics has 9 total employees.

  • What industry is PolyProx Therapeutics in?

    PolyProx Therapeutics’s primary industry is Drug Discovery.

  • Is PolyProx Therapeutics a private or public company?

    PolyProx Therapeutics is a Private company.

  • What is PolyProx Therapeutics’s current revenue?

    The current revenue for PolyProx Therapeutics is .

  • How much funding has PolyProx Therapeutics raised over time?

    PolyProx Therapeutics has raised $5.74M.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process